26.03.18: Not intended for U.S. and UK Media

Bayer announces completion of rolling submission of New Drug Application in the U.S. for larotrectinib for the treatment of TRK fusion cancermehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news